Opinion|Videos|July 25, 2024
Differentiating Bronchiectasis from COPD and Understanding Exacerbations
Author(s)Panagis Galiatsatos, MD
A pulmonary and critical care medicine physician discusses how bronchiectasis compares with other chronic respiratory disorders, highlighting the differing signs and symptoms.
Episodes in this series
Video content above is prompted by the following questions:
- How is bronchiectasis different from other chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD) or asthma?
- How do the exacerbations in bronchiectasis differ from those in COPD in terms of frequency, severity, and management?
Related to this article
North Carolina experts discussed CLL, breast cancer, and myeloma treatments and how to expand access to complex cancer care beyond academic centers.
The IRA's Medicare out-of-pocket cap is easing costs for patients with cancer, but community oncology leaders warn price cuts are straining practices.
A follicular lymphoma survivor shares axi-cel CAR T-cell therapy highs, experiences with severe CRS and neurotoxicity, and why access to care and clinical trials improve quality of life.
Biomarker testing, referrals, screening, treatment access, and clinical trial barriers were examined during this recent IVBM.
Oncologists say advances in testing and treatment are outpacing staffing, pay, and access.
Home NB-UVB phototherapy matches office results, boosts psoriasis treatment adherence, and may improve access, but long-term safety, equity, and oversight lag.
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.